• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE EMERGE¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE EMERGE¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number H7493919315350
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vasoconstriction (2126)
Event Date 12/08/2017
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id 2134265-2018-00187, 2134265-2018-00188, 2134265-2017-12742, and 2134265-2017-12746.It was reported that vessel recoil occurred.The chronic totally occluded lesion was located in the mid right coronary artery (rca).After a 6f non-bsc guide catheter and 3 non-bsc guide wires crossed the lesion, three emerge balloon catheters (2.00x15mm, 3.00 x 15mm and 3.50 x 15mm) were used for pre-dilatation of the distal to proximal portion of the vessel.A 3.00 x 38mm non-bsc stent was deployed in the distal rca after some resistance was encountered.A 4.00 x 48mm synergy¿ drug-eluting stent was advanced to the mid to distal rca but there was resistance when crossing the bend and the device failed to cross the lesion.After multiple attempts, the physician decided to remove the device but the stent dislodged in the radial artery.The physician slowly massaged the arm and removed the stent using a pair of forceps.The physician switched to vascular access via the femoral artery and it was noted that the rca was totally occluded again.A non-bsc guide wire crossed the lesion and pre-dilatation was performed with the 3.50 x 15mm emerge balloon and a 4.50 x 10mm non-bsc balloon.A 4.00 x 38mm synergy¿ drug-eluting stent was advanced but delivery to the mid to distal section of the vessel failed.After multiple attempts, the whole system was disengaged from the vessel.The vessel was reengaged and it was noted that the rca was occluded again.A non-bsc guide wire crossed the lesion and pre-dilatation was performed using the 3.50 x 15mm emerge balloon and a 5.00 x 15mm non-bsc 5.00 x 15 balloon.A 4.00 x 28mm synergy¿ drug-eluting stent was advanced but still failed to cross the lesion.The whole system was disengaged from the vessel after multiple attempts.When the system was re-engaged, it was noted that the vessel has recoiled.The physician decided to only stent the short culprit lesion using a short stent.A 3.50 x 16 synergy¿ drug-eluting stent was advanced but it still could not be delivered and when the device was removed, it was noted that the strut has deformed.The procedure was completed with a 3.50 x 18 non-bsc stent which was aided by a guidezilla guide extension catheter.No further patient complications were reported and the patient's status was stable.
 
Manufacturer Narrative
Upn- search corrected from unk731 - emerge - cmc - (b)(4) (intervent cardio) - 30000 to h7493919315350 - fg emerge mr, ous 3.50mm x 15mm - 39193-1535.Upn corrected from unk731 to h7493919315350.Catalog/model #, device lot number, device expiration date, complainant country, and device manufactured date updated.(b)(4).
 
Event Description
Same case as mdr id 2134265-2018-00187, 2134265-2018-00188, 2134265-2017-12742, and 2134265-2017-12746.It was reported that vessel recoil occurred.The chronic totally occluded lesion was located in the mid right coronary artery (rca).After a 6f non-bsc guide catheter and 3 non-bsc guide wires crossed the lesion, three emerge balloon catheters (2.00x15mm, 3.00 x 15mm and 3.50 x 15mm) were used for pre-dilatation of the distal to proximal portion of the vessel.A 3.00 x 38mm non-bsc stent was deployed in the distal rca after some resistance was encountered.A 4.00 x 48mm synergy¿ drug-eluting stent was advanced to the mid to distal rca but there was resistance when crossing the bend and the device failed to cross the lesion.After multiple attempts, the physician decided to remove the device but the stent dislodged in the radial artery.The physician slowly massaged the arm and removed the stent using a pair of forceps.The physician switched to vascular access via the femoral artery and it was noted that the rca was totally occluded again.A non-bsc guide wire crossed the lesion and pre-dilatation was performed with the 3.50 x 15mm emerge balloon and a 4.50 x 10mm non-bsc balloon.A 4.00 x 38mm synergy¿ drug-eluting stent was advanced but delivery to the mid to distal section of the vessel failed.After multiple attempts, the whole system was disengaged from the vessel.The vessel was reengaged and it was noted that the rca was occluded again.A non-bsc guide wire crossed the lesion and pre-dilatation was performed using the 3.50 x 15mm emerge balloon and a 5.00 x 15mm non-bsc 5.00 x 15 balloon.A 4.00 x 28mm synergy¿ drug-eluting stent was advanced but still failed to cross the lesion.The whole system was disengaged from the vessel after multiple attempts.When the system was re-engaged, it was noted that the vessel has recoiled.The physician decided to only stent the short culprit lesion using a short stent.A 3.50 x 16 synergy¿ drug-eluting stent was advanced but it still could not be delivered and when the device was removed, it was noted that the strut has deformed.The procedure was completed with a 3.50 x 18 non-bsc stent which was aided by a guidezilla guide extension catheter.No further patient complications were reported and the patient's status was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMERGE¿
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7174483
MDR Text Key96700803
Report Number2134265-2018-00189
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
K113220
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/16/2020
Device Model NumberH7493919315350
Device Catalogue Number39193-1535
Device Lot Number20911230
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/11/2017
Initial Date FDA Received01/09/2018
Supplement Dates Manufacturer Received01/10/2018
Supplement Dates FDA Received02/03/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/16/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE CATHETER: AL1.0 6F; GUIDE WIRE: CORSAIR/ FIELDER F/ GAIA 2ND
Patient Outcome(s) Required Intervention;
Patient Age55 YR
-
-